Dr. Rabindera Nath Mehrotra

M.B.B.S, MD(MED), D.M(endocrinology), DNB(endocrinology)
Diabetologist
+ Years Experience

Educational Qualification

  • M.B.B.S in 1987 at M.L.N. MEDICAL COLLEGE, ALLAHABAD U.P,  INDIA
  • MD (MED) in 1991 at M.L.N. MEDICAL COLLEGE, ALLAHABAD U.P,  INDIA
  • D.M (ENDOCRINOLOGY) in 1996 at SANJAY GANDHI  PGI LUCKNOW. UP.  INDIA
  • DNB (ENDOCRINOLOGY) in 1996 at DIPLIOMATE OF NATIONAL BORAD OF EXAMINATION, NEW DEHLI. INDIA
  • C.C.D- CERTIFIED CLINICAL DENSITOMETRIST 2002 -2017 at THE INTERNATIONAL SOCIETY FOR CLINIAL DENSITOMETRY

Research Experience

  1. A Multi centric, Randomized, Double blind, 3+2 year Trial in Osteoporosis– “PEARL TRIAL”. (Published- Title: Lasafoxifene in postmenopausal women with osteoporosis, NEJM, Volume- 362, Pg- 686-696, 2010.)
  2. A Multi centric, Randomized, Double Blind, 5 year Trial in Osteoporosis– “GENERATIONS TRIAL”.
  3. A Multi centric -A Phase 2B Long-Term, Randomized, Open-Label Safety and Tolerability Trial Comparing with routine care in patients with chronic painful Diabetic peripheral neuropathy.
  4. A Multi Centric, Randomized Trail on Osteoporosis Phase 3, Open Label Trial for Parathyroid Hormone. (A Randomized Control Open labeled study in India)
  5. A Multi Centric Phase 3 Trial Randomized, Double Blind- Comparison of Two different Statins in patients with Type II Diabetes Mellitus.
  6. A Multi Centric Phase 4 Trial Randomized– For Type II Diabetes Mellitus -The Durability of Twice Daily Insulin Lispro low mixture compared to once-daily Glargine in patients with type-2 Diabetes and inadequate Glycemic control. Published

Published

  1. A Multi Centric Phase 3 Trial, Randomized, Double Blind- Comparing the Efficacy and safety of a fixed combination of fenofibrate and metformin vs Metformin alone in subjects with type 2 diabetes mellitus and dyslipidemia not appropriately controlled with a statin.
  2. A Multi Centric Phase 3 Trial, Durable Trial Randomized-For Type- 2 DM – Comparison of Premixed Insulin Lispro Low Mixture and Mid Mix regimens with separate Bolus Insulin Injections in patient with inadequate glycemic. control on OHA who consume light breakfast
  3. Diabetic peripheral neuropathy- Neuropathic Pain: “A Cross Sectional Survey of Burden of illness”.
  4. A Multi Centric Phase 3 Trial Randomized “A Phase 2/3, Placebo-Controlled, Efficacy and Safety Study of Once-Weekly, Subcutaneous LY2189265 Compared to Sitagliptin in Patients with Type 2 Diabetes Mellitus on Metformin.
  5. International Growth Database survey.
  6. A randomised, open-label, parallel-group, multi-centre trial comparing the efficacy and safety of 2 devices one injection device to other transjection device of growth hormone in children with idiopathic growth hormone deficiency.
  7. International Diabetes Management Practices Study.

Publications

ORIGINAL ARTICELS

  1. Extra Hepatic Portal Venous Obstruction in Children: Anthropometry, Growth hormone and Insulin like Growth Factor-1. Mehrotra RN, Bahtia V, Dabadghao P, Yachha SK. Journal of Pediatric Gastroenterology and Nutrition. Nov 25 (5) 520-23. 1997.
  2. B Cell Function and Insulin sensitivity in Tropical Calcific Pancreatitis from North India. Mehrotra R.N, Bhatia E, Chaudari G. Metabolism 46(4), 441-44, April 1997.
  3. Growth Charts Suitable for evaluation of Indian children. Khadgwat, Dabadghao P, Mehrotra RN, Bhatia V. Indian Pediatrics, Sep 35(9) 859- 65.1998.
  4. Ectopic ACTH syndrome due to Bronchial Carcinoid Tumor. A case report. 1998, 35(2) 73-6.
  5. The Clinical Spectrum of Fibro Calculous Diabetes in North India..Mittal N, Mehrotra R N, Agarwal G, Rajeswari, Choudari G, Sikora S, Bhatia E. Natl Med J India 2002 Nov-Dec; 15(6): 327-31
  6. Genetic analysis of SRD5A2 gene in Indian patients with 5 alpha reductase deficiency. Ravi Sahu 1, Raman Boddula 1, Pankaj Sharma 1, Vijayalakshmi Bhatia 1, Ronda Greaves 2, Sudha Rao 3, Meena Desai 4, Ashish Wakhlu 5, Shubha Phadke 6, Manoj Shukla1, Preeti Dabadghao 1, Ravi N Mehrotra 7, Eesh Bhatia 1 ( Accepted for publication)

REVIEW ARTICELS

  1. Coronary Heart Disease in Diabetes. Role of hyperglycemia and hyperinsulinemia. Mithal A, Mehrotra R.N. International Journal of Diabetes in developing Countries. Vol 15(3) 1995.

Contact

Rabindera Nath Mehrotra

Health Connect is an initiative by Health Connect International Pty Ltd., Australia,
Bangladesh Office:
Mehnaz Mansur Tower 11/A, Ground Floor Road No: 130, Gulshan 1. Dhaka, 1212
Head Office:
PO Box 2443, Templestowe Lower, Victoria, 3107, Australia
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material or content on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website - bdhci.com
Copyright © 2023-24| All Rights Reserved